Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Dried Blood Spot Testing with AmplideX® SMA Plus* Kit Resolves SMN1 and SMN2 Exon 7 Copy Numbers and More
Sarah Edelmon, Walairat Laosinchai-Wolf, Laura Blasco-Pérez, Mar Costa-Roger, Ivon Cuscó, Gary J Latham, Eduardo F Tizzano, and John N Milligan
Detection of SARS-CoV-2 Armored RNA Quant® in Global Interlaboratory Harmonization Study
Democratizing Carrier Screening: A 35-Gene Panel of Routine and Challenging Targets Resolved Using a Single Workflow
James Hernandez, Bradley Hall, Jon Kemppainen, Julie Thibert, Cody Edwards, Liangjing Chen, Ryan Routsong, Chris Fraher, Theodore Markulin, Melissa Church, Jacob Wisotsky, Jonathan Turner, Justin Janovsky, Stela Filipovic-Sadic, Gary J Latham, Brian C Haynes and Sarah Statt
Enabling Single-Platform Testing and Carrier Screening of the FMR1, SMN1/2, and CFTR Gene Trio
Sarah Edelmon, Walairat Laosinchai-Wolf, Gary J Latham, and John N Milligan
QuantideX qPCR BCR-ABL IS Kit and ipsogen BCR-ABL1 Mbcr IS-MMR Kit Yield Highly Correlated Results
Adrian Lara, Ion Beldorth, Keri Jefferson, Justin T Brown
Analytical Validation of a PCR/CE Assay that Phases SNPs with CAG-Expanded Alleles for Selecting Huntington Disease Patients for Allele-selective Treatments
Ashima Sharma1, Walairat Laosinchai-Wolf1, Erika Mitchen1, Deepa Eveleigh1, Kortney Wilkinson-Busha1, Jonathan Turner1, Melissa Church1, Adrian Lara1, Carleen Gentry2, Jaya Goyal2, Ramakrishna Boyanapalli2, Bernard Andruss1 and Gary J Latham1 1Asuragen, a Bio-Techne Brand, Austin, TX; 2Wave Life Sciences USA, Inc., Cambridge, MA
A Single-Assay Solution for Expanded Carrier Screening Relieves Existing Workflow Constraints and Provides More Comprehensive Analysis
Sarah Statt, Jon Kemppainen, Melissa Church, Cody Edwards, Jonathan Turner, Justin Janovsky, Stela Filipovic-Sadic, Julie R Thibert, Bradley Hall, Liangjing Chen, Theodore Markulin, James Hernandez, Jacob Wisotsky, Brian C Haynes, and Gary J Latham
Method Comparison Between Two Commercially Available BCR-ABL1 Quantitative Kits
Adrian Lara, Ion Beldorth, Keri Jefferson and Justin T Brown
Verification of a Targeted PCR/CE CFTR Assay and Companion Software that Addresses 93% Mutation Prevalence across Diverse Ethnic Groups
Connor Parker, Kevin Kelnar, Elliot Hallmark, Sarah Edelmon, Shobha Gokul, Pranesh Rao, John N Milligan and Bradley Hall
A Deep Learning-Powered Genotyping System for C9orf72 Hexanucleotide Repeat Expansions Enables High Throughput Genetic Analysis
Ryan Routsong, Adrian Gonzalez, Lando Ringel, Jacob Ashton, Sarah N Statt, Gary J Latham and Brian C Haynes, Department of Research and Development
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top